|
Pronunciation |
|
(ETH
oh
toyn) |
|
|
U.S. Brand
Names |
|
Peganone® |
|
|
Generic
Available |
|
No |
|
|
Synonyms |
|
Ethylphenylhydantoin |
|
|
Pharmacological Index |
|
Anticonvulsant, Hydantoin |
|
|
Use |
|
Generalized tonic-clonic or complex-partial seizures |
|
|
Pregnancy Risk
Factor |
|
D |
|
|
Contraindications |
|
Hepatic abnormalities; hematologic disorders; hypersensitivity to
ethotoin |
|
|
Adverse
Reactions |
|
>10%:
Central nervous system: Psychiatric changes, slurred speech, trembling,
dizziness, drowsiness
Gastrointestinal: Constipation, nausea, vomiting
1% to 10%:
Central nervous system: Drowsiness, headache, insomnia
Dermatologic: Skin rash
Gastrointestinal: Anorexia, weight loss
Hematologic: Leukopenia
Hepatic: Hepatitis
Renal: Increase in serum creatinine |
|
|
Drug
Interactions |
|
May increase the metabolism of theophylline |
|
|
Usual Dosage |
|
Oral:
Adults: 250 mg 4 times/day after meals, may be increased up to 3 g/day in
divided doses 4 times/day |
|
|
Dietary
Considerations |
|
Should be administered after meals |
|
|
Mental Health: Effects
on Mental Status |
|
Drowsiness and dizziness are common; may cause insomnia or
confusion |
|
|
Mental Health:
Effects on Psychiatric
Treatment |
|
None reported |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
Take exactly as directed (do not increase dose or frequency or discontinue
without consulting prescriber). While using this medication, do not use alcohol
and other prescription or OTC medications (especially pain medications,
sedatives, antihistamines, or hypnotics) without consulting prescriber. Maintain
adequate hydration (2-3 L/day). You may experience drowsiness, dizziness, or
blurred vision (use caution when driving or engaging in hazardous tasks);
nausea, vomiting, loss of appetite, or dry mouth (small frequent meals, good
mouth care, chewing gum, or sucking on lozenges may help); constipation
(increased exercise, fluids, or dietary fruit and fiber may help). Diabetics
need to monitor serum glucose closely (may alter antidiabetic medication
requirements). If used for seizures, wear identification of epileptic status and
medication. Report CNS changes, mentation changes, or changes in cognition;
difficulty breathing or shortness of breath; muscle cramping, weakness, tremors,
changes in gait; persistent GI symptoms (cramping, constipation, vomiting,
anorexia); changes in urinary pattern, chest pain or palpitations, unusual
bruising or bleeding (mouth, urine, stool); worsening of seizure activity, or
loss of seizure control. Pregnancy precautions: Do not get pregnant while
taking this medication; use appropriate barrier contraceptive measures. Consult
prescriber if breast-feeding. |
|
|
Dosage Forms |
|
Tablet: 250 mg, 500 mg |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|